[go: up one dir, main page]

CA1063131A - Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use - Google Patents

Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use

Info

Publication number
CA1063131A
CA1063131A CA232,800A CA232800A CA1063131A CA 1063131 A CA1063131 A CA 1063131A CA 232800 A CA232800 A CA 232800A CA 1063131 A CA1063131 A CA 1063131A
Authority
CA
Canada
Prior art keywords
reacted
acid
phosphoric acid
organic solvent
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA232,800A
Other languages
French (fr)
Inventor
Hansjorg Eibl
Stefan Kovatchev
Walter Diembeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften
Application granted granted Critical
Publication of CA1063131A publication Critical patent/CA1063131A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/10Phosphatides, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)

Abstract

SYNTHETIC ALKYL ESTERS OF PHOSPHOLIPID ACID, STRUCTURAL ANALOGS
THEREOF AND A PROCESS FOR THEIR MANUFACTURE AND THEIR USE
Abstract of the Disclosure:
Synthetic alkylesters of phospholipid acid, the structu-ral analogues thereof, their physiologically acceptable salts as well as a process for preparing them and their use.

Description

HOE 74/B 036 ~ ~
~63:131 The present invention relates to synthetic alkyl esters of phospholipid acid, the structural analogs and the physiologi-cally acceptable salts thereof and to a process for their manu-facture.
The process of the invention comprises A) reacting a primary alcohol of the formula wherein R3 stands for a saturated or unsaturated straight-chain or branched alkyl group of one to 25 carbon atoms, which may be substituted by halogen, a cycloalkyl group or an aromatic group, with phosphorus oxychloride in the presence of an inert organic solvent, and B) reacting the resulting phosphorylation agent oE the ormula Cl \

wherein R3 is defined as above, with a polyhydroxy compound hauing a free hydroxy group and the further hydroxy groups of which are protected.
The process of the present invention permits the preparation of large numbers of alkyl esters of phospholipid acid by simply reacting a primary alcohol with phosphorus oxychloride. The resulting phosphorylation agent of formula II may be reacted directly without isolation with the polyhydroxy compound without having to distil the phosphorylation agent.
In the above formula I, R3 may stand for a saturated or un-saturated straight-chain or branched alkyl group having 1 to 25 carbon atoms, for example 1 to 23, 1 to 21, 1 to 18, 1 to 16, 3 to 25, 3 to 23, 3 to 21, 3 to 18, 3 to 16, 3 to 14, 3 to 12, .~ - 2 - ~

: . . .. ,. :: .. . ., : ,, ,,, ,, ............... : .. : -.~

. . ~ . ::. , . : : ~ .: .

~063131 liOE 74/~ 036 3 to 10, 4 to 25, 4 to 21, 4 to 18, 4 to 1~, 4 to 12, 6 to 25, 6 to 18 or 6 to 14 carbon atoms.
The group represented by R3 may contain one or more double bonds or triple bonds and may be substituted by halogen, such as bromine, chlorine, iodine or fluorine. It may also be substituted by one or more cycloalkyl groups having 4 to 8, preferably 5 to 7, carbon atoms, or by 1 or more aromatic groups, such as phenyl or naphthyl groups or substituted phenyl groups. The reaction of the primary alcohol with the phosphorus oxychloride yields the phosphorylation agent of the general formula II.
The reaction of the primary alcohol with phosphorus oxy-chloride is carried out in the presence of an inert organic sol-vent, for example halogenated hydrocarbons, such as chloroform or carbon tetrachloride. The reaction is carried out without adding a base. The molar ratio of alcohol to phosphorus oxy chloride is generally 1:2, but it may of course b~ varied within ;
certain limits. For example, 1 mol of alcohol may be reacted with ;~
1.7 to 2.3 mols of phosphorus oxychloride. The reaction is generally carried out under anhydrous conditions. The reaction temperature is generally room temperature but temperatures of -10 to ~80C, for example from 20C to ~0C, may also be applied.
The reaction time depends on the temperature chosen and ranges from half an hour to 15 hours generally from 10 to 12 hourst when room temperature is applied. ~
When the reaction which can be controlled by thin-layer ;;
chromatography is complete excess phosphorus oxychloride and excess hydrochloric acid may be eliminated in a hydrogen vacuum, for example at 30 to 35C. The alkyl phosphoric aci~ dichloride remains as a residue. This alkyl phosphoric acid dichloxide may --~63~3~ HOE 74/B 036 directly be used for the phosphorylation reaction without further purification. A distillation is not necessary. Compared to known phosphorylation methods, this is a substantial advantage since many alkyl phosphoric acid dichlorides tend to decompose in an explosive manner.
The phosphorylation agent of the general formula II is very reactive and reacts with a large number of polyhydroxy compounds containing a free hydroxy group. The reaction is preferably carried out with exclusion of moisture in an inert organic solvent, for example a chlorinated hydrocarbon, such as chloroform or carbon tetrachloride. Other organic solvents, such as toluene or xylene or benzene may also be used; absolute solvents are however pre-ferred.
The reaction of the phosphorylation agent with the poly-hydroxy compound may be carried out within a wide range of -temperature, for example from -10C to +50C, preferably at room temperature. The reaction time used depends on the reaction tem-perature chosen, it ranges generally from half an hour to 5 or 6 hours. The phosphorylation reaction is preferably carried out in the presence of a base, for example of triethyl amine.
The phosphorylation agent obtained according to this in-vention allows a number of alkyl esters of phospholipid acid to be obtained. As polyhydroxy compounds, any polyhydroxy compounds may be used which contain a free hydroxy group and the other hydroxy groups of which are protected, for example by esteri-fication, e~herification, acetal- or ketal formation. In general, the polyhydroxy compound used is a glyceride or a correspondingly higher homolog. It is thus possible according to the invention to phosphorylate erythritol, pentitol or hexitol derivatives but .. .. .. . . .

;: , . : . : . :
,. . . , ' ! ' -' : ' ';

~63131 flOE 74/B 036 also cyclic polyhydroxy compounds, such for example as cyclic saccharic alcohols. Generally, monosaccaride derivatives and oligo-saccharide derivatives may be ùsed according to the process of the invention.
The process of the present invention may be carried out us-ing racemic mixtures of pure optical isomers. The present invention also provides the products obtained according to the process of this invention. As already mentioned above, this process yields a large variety of different alkyl esters of phospholipid acid, of which individual groups are hereinafter cited as example that can be prepared according to the process of the invention.
1. Alkyl esters of phospholipid acid Hl- o-cO-R~ III

OH ;~
H C - O - CO - R

¦ OH
~2C - O - CO - R2 In the formulae III and IV, R3 is defined as above. Rl and R2 each stand for a saturated or unsaturated straight-chain or branched alkyl group having 5 to 25, 5 to 21 or 5 to 18, 5 to 16 carbon atoms, which may also be substituted by 1 or more, i.e~
2, 3, 4 and more halogen atoms, such as fluorine, chlorine, bromine or iodine atoms. The alkyl groups may also be substituted by a cycloalkyl group or an aromatic ring. If the alkyl groups are substituted by a cycloalkyl group, this may contain 4 to 8, pre-ferably 5, 6 or 7, carbon atoms. I~ the alkyl groups are sub-,. ~ , .

- . . , - ., , ~ : . .

~OE 7~/B 036 ~63~31 stituted by an aromatic ring, this may for example be a phenyl ring ox a naphthyl ring which may also carry further substituents.
Starting substances are racemic or optically active 1,2- or 1,3-diglycerides having saturated, unsaturated, branched or halo-genated fatty acids or fatty acids which contain a cycloalkane or aromatic ring.
2. Lyso compounds of compounds of Group 1 Starting compounds are l-acyl-2-benzyl glycerols or l-benzyl-2-acyl glycerols. The phosphorylation reaction provides the lyso compounds by catalytic debenzylation. Unsaturated compounds are prepared with the help of protective groups which may be eliminated by a mild acid hydrolysis.
The starting compounds may also be obtained by biochemical methods from the compounds of Group 1 by enzymatic splitting with the phospholipases Al and A2.
3. Analogs with saccharic alcohols (HC - O - CO ~ R)x V
H2C ~

In the above formula V, R3 is defined as above, and R has the same meaning as Rl and R2, and X stands for zero or an integer of from 1 to 5, i.e. 0, 1, 2, 3, 4 or 5.
Starting substances are acylated saccharic alcohols which contain a free hydroxy group.
4. ~ther analogs of the compounds of Groups 1 to 3 and ether/
ester analogs of the groups of compounds 1 and 3, for example ,, ~.,:,...

..

.

1063131 HOE 74/B 036 ~ ~

H2C -- O - Rl . ~

H2C - O - PO - o - R

OH

H2l Rl HC - O - PO - O ~ R3 VII

I OH
H2C~ ~ ~

In the formulae VI and VII, Rl, R2 and R3 are defined as above.
Starting substances are 1,2- and 1,3-dialkylglycerol ethers or acylglycerol alkyl ethers. The alkyl radicals may be saturated, un~aturated, branched or halogenated and may also contain a cyclo-alkane or an aromatic ring.
5. Dialkyl ketone glycerol_phosphoric acid alkyl esters \C / ~ ~

HC - O \ R2 VIII

OH -H2C - o \
¦ C \ IX

HC - O H

.., . :~
OH ~ -In the above formulae VIII and IX7 Rl, R2 and R3 are defined as above.
Starting substances are the 1,2- and 1,3-dialkyl ketone ~-glycerols or the corresponding acetals which may be obtained from `' - 7 -~063~31 HOE 74/B 036 glycerol or 2-benzyl glycerol by reaction with the corresponding ketones or aldehydes. The ketones or aldehydes may be saturated, unsaturated, branched or halogenated and ~lay also contain a cycloalkane or an aromatic ring.
6. Cycloalkyl ketone glycerol phosphoric acid alkyl esters H C - O
2 \
/C (CH2)y X
HC - O

H2C - O - PO - o - R3 OH
H C - O
2 \ ~,_-----__~

/ (CH2)y XI
HC - O ~

OH
In the above formulae, R3 is defined as above, and y stands for an integer of from 5 to 32, for example 5 to 28, 5 to 24, 5 to 18, 5 to 16, 5 to 14, 5 to 12, 5 to 10, 5 to 8.

Starting substances are 1,2- and 1,3-cycloalkyl ketone glycerols which may be obtained from glycerol or 2-benzylglycerol by reaction with the corresponding cycloalkanone.
7. Alkyl esters of desoxylyso phospholipid acid HzC - O - CO - R

(I 2~m XII
H2C - O - IO - o - R3 OH

, ' :
, .
- 8 -, .~ .
. . :. ~ , , , . . ~ , . ;

-:
. .
: ~ ~ : . ::: .

31 ;
( 2)m ;~
¦ XIII
HC - O - CO - R

OH

( CH2 ) p ' :.
HC - O - CO ~ Rl XIV ~
(fH2) q ~: .
10 H2C - O - lo - o - R3 OH
In the above formulae, Rl and R3 are defined as above, and m stands for zero or for an integer of rom 1 to 14, for example for 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, and p ~ ~ = m.
15 As starting substances, the monoacylalkane diols are preferred. ~
The alkane diols may be saturated, unsaturated, branched or ~ ;
halogenated and may also contain a cycloalkane or an aromatic ~
ring. ~ ~ ;
8. Ether analogs of compounds of Group 6 Methods for the preparation of the said starting substances are known (s. publication of A.J. Slotboom and P.P.N.
Bonsen "Chem. Phys. Liquids" (1970), pages 301 to 398).
The compounds of the invention corresponding to formulae I, III to VI have valuable pharmacological properties and they are potent surfactants which, owing to their structural analogy with the phospholipids present in the cell membranes, are able to influence the surface activity of these membranes. Their negative charge a~ physiological p~-values is moreover capable of influencing the charge of biological membranes.
_ g _ ,.
,~ .

: , ~- : -: .:: : . . . . .. ., . :: : , . . .

1063~3~ HOE 74/B 036 ~

Owing to these properties, these substances can be expected to modify the activity of pharmaceuticals by increasing their ahsorbability and their distribution in the organism~ The compounds are valuable additives in the manufacture of drugs.

The compounds of formulae I and III to IV are readily dis-persible in water and give emulsions which are stable over a wide pH range. It is surprising that these emulsions are even still stable at a pH of 1.0 whilst, for example, emulsions of lecithin precipitate in flakes already at a pH of 2Ø
Dispersions of the said compounds are also suitable to pass unchanged through the stomach (pH 1.5) and to improve, for example, the absorbability of fats.

The compounds of formulae II, VII and VIII are potent surfactants and have a lytic activity on natural membranes (for example erythrocytes). They may therefore be used in many ways for the disintegration of these membranes or, when applied in sub-lytic dosages, for a modification of the properties of membranes, which again may influence the activity of pharma- ~
ceutical compositions. `

The compounds of the invention generally have very good emulsifying properties. Having a structure similar to that of natural products, they are physiologically acceptable . . ~, . . , ; . . , . :
. : ........ ' ' . :: ', - . ~ , , . : . , ,. : ~ , , -: , . , ~::
., : :.
., . . . . , . . - , 1~63131 HOE 74/B 03Ç

in foodstuffs and may therefore be used for a variety of applications. ~hen added to margarine, they bring about a better linkage to water, thus preventing it from splashing in the frying pan and imparting to it butter like properties when used for frying. They may be used in sweets for emulsifying sirup with fat and also prevent: the fat getting -~`
rank. When applied for cosmetic purposes and for the making of soaps small additives of the products of the invention improve the suppleness and absorption of ointments, creams, tooth pastes, soaps and the like.

The following examples illustrate the invention.

Example 1 General preparation of alkylphosphoric acid dichlorides:
80 g (0,6 mol) of POC13 (freshly distilled, boiling point ~-105 to 107C) in 100 ml of absolute chloroform (distilled for 90 minutes with circulation over P2O5) were placed in a three-neck flask equipped with cooler, dropping funnel and nitrogen inlet tube. While stirring by means of a magnetically operated stirrer, nitrogen was slowly fed in, and 0.3 mol of the said alcohol in 50 ml of absolute chloro- ~ -form was added dropwise. The mixture was stirred for 12 hours ; ~
~ ' -- 1 1 -- , .. ...

~06313~ HOE 74/B 036 at room temperature, and the resulting hydrogen chloride, excess POC13 and chloroform were eliminated at 30C in the rotary evaporator. To eliminate any trace of POC13, 50 ml of toluene were added and likewise drained off. ~;

The remaining oily substance, i.e. the alkyl-phosphoric acid dichloride, can be reacted further without purification.
Distillation was performed on some of low boiling alkyl phosphoric acid dichlorides and the following boiling points were observed: boiling point at 10 mm Hg CH3-O-PO-C12 44 to 47C
C2H5-O-Po C12 54 to 56C
C3H7-O-PO C12 66 to 68C
C H -O-PO-C12 85 to 87C
. .
The reaction provided a yield of 90 to 100~ and can be ~

controlled by thin-layer chromatography. ~ ;`
. ,~
Example 2 .
Preparation of ~-bromoalkyl-phosphoric acid dichlorides:
a) Preparation of bromo alcohols having different chain length according to a simple process:
Compounds of formula Br - (CH2)n - OH
in which n stands for the integer of 4 to 10, were synthesized. ;;

:

. ~ .
.. , . . . . . ~ ` . . .. .,, ,,, ,, ,, : : : . .. . . .

HOE 74/~ 036 ~063~3~ - -The starting products were diol of corresponding chain length having terminal alcohol functions. Since only one ~;~
bromine atom per diol molecule was to be introduced, a method had to be chosen wherein the reaction product was immediately eliminated from the proper reaction medium and ~; ;
thus further reaction was excluded. For this purpose the extraction method was suitable.

In a round flask the diol and hydrobromic acid were placed.
The starting products were overlaid with petroleum benzine or with benzene/petroleum benzine. The selection of the extraction agent depended on the insolubility of the diol and on the good solubility of the reaction products therein.
The round flask was equipped with a reflux condenser. While energetically stirring by means o a magnetically operated stirrer, the mixture was then refluxed by means of an adequate heating device until the starting product had completely reacted. The proceeding reaction was checked by means of ~-thin-layer chromatograms.

Subsequently the extraction medium phase was separated and dried with calcium sulfate. After the siccative had been filtered off the extraction medium was eliminated in the rotary evaporator. The residue was subjected to a fractionated distillation in an oil pump vacuum.

:

-- , : . . .

.. , . . . .: :.

:: : -: : ~,, : :. ;.:: :: . ., :;

1~63131 HOE 74/B 036 The yields were about 80 to 95% o~ the theoretical yield, calculated on the diol used.

4-~romobutanol-(1) and 5-bromopentanol-(1) were prepared as follows: ~;

0,25 mol = 22,5 g of 1,4-butanediol or 26 g o~ 1,5-pentane-diol, 0,48 mol = 80 g of HBr(47~, 500 ml of benzene and 50 ml of petroleumbenzine, boiling point 100 to 140C, were refluxed for 6,5 and 6 hours, respectively.
The rest of the brominated alcohols was prepared as ~ollows~

0,25 mol = 29,6 g of 1,6-hexanediol or the corresponding diol, 0,48 mol = 80 g of HBr(47%), 1500 ml of petroleum benzine, boiling point 100 to 140C, were refluxed.
Reaction product Reaction time physical constants 4-bromobutanol-(1) 6,5 hr b.p.(0.7 mm Hg) 58 to 60C5-bromopentanol-~1) 6 hr b.p.(0.5 mm Hg) 72 to 74C6-bromohexanol-tl) 1,5 hr b.p.(0.6 mm Hg) 85 to 87C7-bromoheptanol-~1) 1,5 hr b.p.(0.5 mm Hg) 87 to 89C8-bromooctanol-(1) 1 hr b.p.~0.5 mm Hg) 110 to 112C
9-bromononanol-(1) 1 hr b.p.(0.4 mm Hg) 112 to 114C
10-bromodecanol-(1) 30 min b.p.(0.3 mm Hg) 124 to 126C ~-.

-. ,, ., .:, ,. ; .:.- : , , .. : .: . :. . . ,:: .. , :. : ... . :: . .: . :-: :. :i .. : :.

- : :~ : : . .:
-~3~3~ HOE 74/B 036 Including 8-bromooctanol-(1) the reaction products were -colourless liquids. 9-Bromononanol(l) and 10-bromodecanol~
are white and solid products at room temperature. Brominated alcohols of greater chain length may principally be prepared according to the same process. Since these reaction products are all solid products, they are purified by recrystallization.

(b) Preparation of ~ -bromoalkylphosporic acid dichloride:
32 mmol = 30 ml of phosphorus oxytrichloride (freshly distilled, boiling point 105 to 107C) in 70 ml of absolute chloroform tdistilled for 90 minutes with circulation over P205) were placed in a round flask. At room temperature, nitrogen i was introduced into the solution for a short time to expel air.
The flask was equipped with a dropping funnel and sealed air-tight. While stirring by means of a magnetically operated stirrer, 20 mmol of the brominated alcohol of desired chain length in 50 ml of absolute chloroform were added dropwise slowly at room temperature with the exclusion of moisture.
Stirring was continued for about 12 hours. The hydrogen chloride resulting from the reaction as well as excess phosphorus oxytrichloride and chloroform were eliminated at 30C in the rotary evaporator. To eliminate every trace of phosphorus oxytrichloride toluene was added and likewise drained off.

: , : . :: - ~ - ~ :. . :
~:

: : .. , , 1063~31 HOE 74/B 036 The yield was 95 to 100~ and the conversion reaction can be checked by thin-layer chromatography.

Example 3 General preparation of alkylesters of phospholipid acid and of structural analogues thereof:
The phosporylation agent prepared in Example 1 or 2 (0.3 mol~ was dissolved in 100 ml of absolute chloroform (distilled for 90 minutes with circulation over P2O5), and the solution was cooled to 0 to 5C in an ice bath. While stirring by means o a magnetically operated stirrer, 60 g (0.6 mol) of absolute triethylamine tdried over lithiumaluminumhydrlde and freshly distilled) were added dropwise to 50 ml of absolute chloroform. The ice bath was then replaced by a water bath of 20C. While steadily stirring, a solution of the corresponding starting substance (0,15 mol) in 150 ml of absolute chloro-form was added dropwise to the phosporylation mixture.
Checking by means of thin-layer chromatography made sure that the reaction was almost complete already after the drop-wise addition. After another 6 hours at 40C the reaction mixture was freed in the rotary evaporator at 35C from solvent, and the residue was taken up in 450 ml of tetrahydro-furan. While stirring, 1 M sodium acetate solution of pH 8.4 ~ -,. .

. , . . .'. , ' :
' . , ' , , . . ' : ~' , ~0~3~3~ HOE 74/B 036 was added to the suspension or solution of the reaction ;
mixture in tetrahydrofuran until the water phase remained neutral (pH about 7). For this purpose, about 450 ml of lM sodium acetate solution had to be added. The hydrolysed reaction product was extracted as the sodium salt by means of 450 ml of diisopropylether. The water phase was again extracted by means of 200 ml of diisopropylether. The combined diisopropylether extracts were mixed while stirring with 10 g of sodium carbonate to eliminate water and to assure a `
complete conversion of the reaction product into the sodium salt.

For the preparation of derivatives having less than a total o 14 carbon atoms, the reaction solution was acidified with HCl (pH about 2) prior to the extraction with diisopropyl ether. Derivatives having a very short chain were better extxacted as the free acids and can be crystallized by care-fully adding sodium methylate in methanol.

The diisopropylether phase was filtered and the filtrate was evaporated in vacuo. The residue was recrystallized from ethylmethylketone/acetone mixtures~ Generally the resulting reaction products are analytically pure. Otherwise a complete purification of the products is brought about by chromato-graphy on silica gel. The yields of analytically pure product ~ -~
vary between 70 and 90% (calculated on the starting products ', ,' ' .: : . , :- : , . .
: , . , .. . . .
:: . ' , ' ~ . . . ' , :

1063~31 HOE 74/B 036 used).
The following compounds were prepared:
Compound of Group 1:
sn-1,2-dimyristoylglycerol-3-phosphoric acid methyl ester, as ' 32 62 8 (628.8) calculated: C 61.12% H9.94~ P 4.93%.
The data found complied with the calculated values.
Compound of Group 2:
sn-l-myristoylglycerol-3~phosphoric acid methyl ester, as sodium salt, C18H36NaO7P (418.5) calculated: C 51.67~ H 8.67% P 7.40%.
The data found complied with the calculated values.
Compound of Group 3:
1/2,3,4,5-pentapalmitoyl-D-mannitol-6-phosporic acid butyl ester, as sodium salt, C90Hl72NaOl4P (1532.3) calculated: C 70.55% H 11.32~ P 2.02%.
The data found complied with the calculated values.
Compound of Group 4:
/ Glyceroldioctyl etherphosphoric acid-(3)-~-bromoethyl ester, as sodium salt, C21H43BrNaO6P t525.5) calculated: C 48.00% H 8.25% Br 15,21% P 5.90%.
The data found complied with the calculated values.
Compound cf Group 5:
Diheptadecyl ketone glycerol-3-phosphoric acid octyl ester, as sodium salt, C46H92NaO6P (795.21) calculated: C 69.48% H 11.66% P 3.90%.
The data found complied with the calculated values.
Compound of Group 6:
Cyclopentadecyle ketone glycerol-3-phophoric acid-B-bromoethylester, , : . , . ,, ,~ . .:
::
- , . ~ , .

1~63~31 as sodium salt, C20H37BrNap (484-4) calculated: C 49,59~ H 7,70% Br 16,49~ P 6,39%.
The data found complied with the calculated values.
Compound of Group 7:
Oleoylhexanediol-(1,6)-phosphoric acid isopropyl ester, as sodium salt, C27H52NaO6P (526.68) calculated: C 61.57% H 9.52% P 5.88%.
The data found complied with the calculated values.
Compound of Group 8:
Propanediol-(1,3)-hexadecyl ether phosphoric acid hexyl ester, as sodium salt, C25H52NaO5P (486.7) calculated: C 61,70% EI 10,77% P 6,37%.
The data Eound complied with the calculated values.

, . -- 1 9 -- . .
_. .
, , " , .. . . . ~ . ,, :. , , - . : ,, , :

. . , . . , . , . . : . -.

Claims (26)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for the preparation of a synthetic alkyl-ester of phospholipic acid, the structural analogues thereof and the physiologically acceptable salts thereof in which (A) a primary alcohol of the formula wherein R3 represents a saturated or unsaturated straight-chain or branched alkyl group of 1 to 25 carbon atoms, which may also be substituted by halogen, one or more cyclo-alkyl groups or one or more aromatic groups, is reacted with phosphorus oxychloride in the presence of an inert organic solvent, and (B) the resulting phosphorylation agent of the formula wherein R3 is as defined above, is reacted with a polyhydroxy compound, having up to 17 carbon atoms, having a free hydroxy group and the other hydroxy groups of which are protected, and, to produce a salt, the product may be reacted with a physiologi-cally acceptable reactant.
2. A process as claimed in claim 1, in which reaction (B) is carried out in the presence of an inert organic solvent.
3. A process as claimed in claim 1, in which reaction (B) is carried out in the presence of an organic base and with the exclusion of moisture.
4. A synthetic alkylester of phospholipid acid, the structural analogues and physiologically acceptable salts thereof, whenever obtained according to a process as claimed in claim 1, claim 2 or claim 3 or by an obvious chemical equivalent thereof.
5. A process as claimed in claim 1 in which in reaction (A) the solvent is selected from the group of chloroform and carbon tetrachloride.
6. A process as claimed in claim 1 in which in reaction (A) the molar ratio of alcohol to phosphorus oxychloride is in the range of from about 1:2.
7. A process as claimed in claim 1 in which reaction (A) is carried out under anhydrous conditions and at a temperature in the range of from -10 to +80°C.
8. A synthetic alkylester of phospholipid acid, the structural analogues and physiologically acceptable salts there-of, whenever obtained according to a process as claimed in claim 5, claim 6 or claim 7 or by an obvious chemical equivalent there-of.
9. A process as claimed in claim 1 for the preparation of an alkyl ester of phospholipid acid of the formula wherein R1 and R2 are identical or different and each represents a substituted or unsubstituted alkyl group having 5 to 25 car-baon atoms, and R3 is as defined in claim 1, the structural ana-longues thereof and the physiologically acceptable salts there-of in which (A) a primary alcohol of the formula R3OH wherein R3 is as de-fined in claim 1, is reacted with phosphorus-oxychloride in an inert organic solvent, and (B) the resulting phosphorylation agent is reacted with a poly-hydroxy compound having a free hydroxy group and the addi-tional hydroxy groups are protected and, to product a salt, the product may be reacted with a physiologically accept-able reactant.
10. An alkyl ester of phospholipid acid of the struc-tural formula as set forth in claim 9, whenever obtained ac-cording to a process as claimed in claim 9 or by an obvious chemical equivalent thereof.
11. A process as claimed in claim 1 for the preparation of sn-1,2-dimyristoylglycerol-3-phosphoric acid methylester in which methanol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant methyl-phosphoric-acid-dichloride is reacted with 1,2-dimyristoyl-sn-glycerol in the presence of a base and the resultant product is subsequently isolated.
12. sn-1,2-Dimyristoylglycerol-3-phosphoric acid methyl-ester, whenever obtained according to a process as claimed in claim 11 or by an obvious chemical equivalent thereof.
13. A process as claimed in claim 1 for the preparation of sn-1-myristoylglycerol-3-phosphoric acid methylester in which methanol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant methyl-phosphoric-acid-dichloride is reacted with 1-myristoyl-2-benzene-sn-glycerol in the presence of a base and the resultant product is subse-quently isolated.
14. sn-1-Myristoylglycerol-3-phosphoric acid methylester, whenever obtained according to a process as claimed in claim 13 or by an obivous chemical equivalent thereof.
15. A process as claimed in claim 1 for the preparation of 1,2,3,4,5-pentapalmitoyl-D-mannitol-6-phosphoric acid butyl-ester in which butanol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant butyl-phosphoric-acid-dichloride is reacted with 1,2,3,4,5-pentapalmitoyl-D-mannitol in the presence of a base and the resultant product is isolated.
16. 1,2,3,4,5-Pentapalmitoyl-D-mannitol-6-phosphoric acid butyl-ester, whenever obtained according to a process as claimed in claim 15 or by an obvious chemical equivalent there-of.
17. A process as claimed in claim 1 for the preparation of glycerol dioctyl ether phosphoric acid-(3)-.beta.-bromoethylester in which bromoethyl alcohol is reacted with phosphorus oxychlor-ide in an inert organic solvent, the resultant bromoethyl-phos-phoric-acid-dichloride is reacted with 1,2-dioctyl-glycerol in the presence of a base and the product is subsequently isolated.
18. Glycerol dioctyl ether phosphoric acid-(3)-.beta.-bromo-ethylester, whenever obtained according to a process as claimed in claim 17 or by an obvious chemical equivalent thereof.
19. A process as claimed in claim 1 for the preparation of diheptadecyl ketoneglycerol-3-phosphoric acid octylester in which octanol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant octyl-phosphoric-acid-dichloride is reacted with 1,2-diheptadecylketone-glycerol in the presence of a base and the product is subsequently isolated.
20. Diheptadecyl ketoneglycerol-3-phosphoric acid octy-ester, whenever obtained according to a process as claimed in claim 19 or by an obvious chemical equivalent thereof.
21. A process as claimed in claim 1 for the preparation of cyclopentadecyl ketoneglycerol-3-phosphoric acid-.beta.-bromoethyl-ester in which .beta.-bromoethanol is reacted with phosphorus oxy-chloride in an inert organic solvent, the result .beta.-bromoethyl-phosphoric acid-dichloride is reacted with cyclopentadecylketone-glycerol in the presence of a base and the product is subsequently isolated.
22. Cyclopentadecyl ketoneglycerol-3-phosphoric acid-.beta.-bromoethyl-ester, whenever obtained according to a process as claimed in claim 21 or by an obvious chemical equivalent there-of.
23. A process as claimed in claim 1 for the preparation of oleoyl-hexanediol-(1,6)-phosphoric acid isopropylester in which isopropyl alcohol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant isopropyl-phosphoric-acid-dichloride is reacted with 1-oleoyl-hexanediol-(1,6) in the presence of a base and the product is subsequently isolated.
24. Oleoyl-hexanediol-(1,6)-phosphoric acid isopropyl-ester, whenever obtained according to a process as claimed in claim 23 or by an obvious chemical equivalent thereof.
25. A process as claimed in claim 1 for the preparation of propanediol-(1,3)-hexadecylether phosphoric acid hexylester in which hexanol is reacted with phosphorus oxychloride in an inert organic solvent, the resultant hexyl-phosphoric-acid-di-chloride is reacted with 1-hexadecyl-propanediol-(1,3) in the presence of a base and the resultant product is subsequently isolated.
26. Propanediol-(1,3)-hexadecylether phosphoric acid hexylester, whenever obtained according to a process as claimed in claim 25 or by an obvious chemical equivalent thereof.
CA232,800A 1974-08-06 1975-08-05 Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use Expired CA1063131A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2437833A DE2437833A1 (en) 1974-08-06 1974-08-06 SYNTHETIC ALKYLESTERS OF PHOSPHATIC ACID AND STRUCTURAL ANALOGA, PROCESS FOR THEIR PRODUCTION AND USE

Publications (1)

Publication Number Publication Date
CA1063131A true CA1063131A (en) 1979-09-25

Family

ID=5922579

Family Applications (1)

Application Number Title Priority Date Filing Date
CA232,800A Expired CA1063131A (en) 1974-08-06 1975-08-05 Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use

Country Status (13)

Country Link
JP (1) JPS5143724A (en)
AU (1) AU8368575A (en)
BE (1) BE832181A (en)
CA (1) CA1063131A (en)
CH (1) CH619962A5 (en)
DE (1) DE2437833A1 (en)
DK (1) DK355675A (en)
FR (1) FR2281374A1 (en)
GB (1) GB1523481A (en)
IE (1) IE41442B1 (en)
IT (1) IT1044019B (en)
LU (1) LU73149A1 (en)
NL (1) NL7509364A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56677Y2 (en) * 1976-12-27 1981-01-09
DE3476770D1 (en) * 1983-04-11 1989-03-23 Meito Sangyo Kk Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2750399A (en) * 1949-12-27 1956-06-12 Monsanto Chemicals Process for alkyl phosphoryl dichlorides

Also Published As

Publication number Publication date
IE41442L (en) 1976-02-06
NL7509364A (en) 1976-02-10
IE41442B1 (en) 1980-01-02
BE832181A (en) 1976-02-06
IT1044019B (en) 1980-02-29
LU73149A1 (en) 1977-04-13
DK355675A (en) 1976-02-07
CH619962A5 (en) 1980-10-31
JPS5143724A (en) 1976-04-14
FR2281374A1 (en) 1976-03-05
AU8368575A (en) 1977-02-10
FR2281374B1 (en) 1979-10-05
GB1523481A (en) 1978-08-31
DE2437833A1 (en) 1976-02-26

Similar Documents

Publication Publication Date Title
US4159988A (en) Synthetic phospholipids, a process for their manufacture and their use
Yuan et al. Synthesis and evaluation of phospholipid analogs as inhibitors of cobra venom phospholipase A2
Eibl et al. Synthesis of enantiomerically pure glyceryl esters and ethers. I. Methods employing the precursor 1, 2-isopropylidene-sn-glycerol
US4873355A (en) Process for regioselectively preparing phosphorylated inositols and other cyclitols
WO2013071418A1 (en) Methods for the synthesis of plasmalogens and plasmalogen derivatives, and therapeutic uses thereof
EP0524979A4 (en) 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents
EP0036583A2 (en) Glycerine-3-phosphoric acid halogenalkyl ester, process for its preparation and further processing
CA1063615A (en) Synthetic phospholipids, a process for their manufacture and their use
US4163748A (en) Propane-1,3-diol phosphatides and method of preparing the same
CA1063131A (en) Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use
Baer et al. Synthesis of unsaturated α-phosphatidic acids and α-bisphosphatidic acids. Cardiolipin substitutes. IV
US4160773A (en) Synthetic alkyl esters of phospholipid acid, structural analogs thereof and a process for their manufacture and their use
US5081147A (en) 4-(1-hydroxy-2-substituted amino)ethyl-5-hydroxy-2(5H)-furanones as anti-inflammatory agents
US4751320A (en) Phosphoric ester and process for producing same
US3632692A (en) Organophosphorus anhydrides
WO1992019609A1 (en) Substituted dihydroxy-bis-[5-hydroxy-2(5h)-furanone-4-yl]-alkanes as anti-inflammatory agents
GB1581810A (en) Process for the preparation of phospholipids
JP4677550B2 (en) Cyclic ester compound
Liu et al. Synthesis of novel chiral 2‐oxo‐and 2‐thio‐1, 3, 2‐oxazaphospholidines via asymmetric cyclization of l‐methionol with (thio) phosphoryl dichlorides
EP0043472B1 (en) 3-hydrocarbylthio-2-acyloxypropyl 2-trimethylammonioethyl phosphates, process for producing the same and pharmaceutical preparations containing the same
Massing et al. Synthesis of enantiomerically pure 1-O-phosphocholine-2-O-acyl-octadecane and 1-O-phosphocholine-2-N-acyl-octadecane
JPH06228169A (en) Production of 1-o-acylglycerol 2,3-phosphate
Garcia et al. Synthesis of new ether glycerophospholipids structurally related to modulator
EP0372941A2 (en) Anti-inflammatory 5-hydroxy-2-furanones
US4740609A (en) Phosphoric esters and process for preparing same